Literature DB >> 9806047

Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients.

T Lazzarotto1, S Varani, P Spezzacatena, P Pradelli, L Potena, A Lombardi, V Ghisetti, L Gabrielli, D A Abate, C Magelli, M P Landini.   

Abstract

Previous studies have demonstrated that maturation of cytomegalovirus (CMV)-specific antibodies in solid organ transplant recipients is delayed after primary CMV infection. To investigate the clinical significance of this finding, the avidity indices of anti-CMV antibody were determined in parallel with other serologic and virologic parameters in serial serum samples from 24 solid organ transplant recipients who had primary CMV infection that began during the first 3 months after transplantation. The data obtained show that a delay in antibody maturation is significantly correlated with a long persistence of positive antigenemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806047     DOI: 10.1086/515671

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.

Authors:  Harry E Prince; Amy L Leber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.

Authors:  Harry E Prince; Mary Lapé-Nixon; Susan M Novak-Weekley
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

3.  Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.

Authors:  Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Takako Tabata; Lenore Pereira
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

4.  The role of maternal screening in diagnosing congenital cytomegalovirus infections in highly immune populations.

Authors:  F Şahiner; M Honca; Y Çekmez; A Kubar; T Honca; M K Fidanci; T Purtuloğlu; M Yapar
Journal:  Ir J Med Sci       Date:  2014-06-04       Impact factor: 1.568

5.  Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence.

Authors:  Proscovia B Namujju; Lea Hedman; Klaus Hedman; Cecily Banura; Edward K Mbidde; Dennison Kizito; Romano N Byaruhanga; Moses Muwanga; Reinhard Kirnbauer; Heljä-Marja Surcel; Matti Lehtinen
Journal:  BMC Res Notes       Date:  2011-06-06

Review 6.  The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.

Authors:  Smita Y Patel; Javier Carbone; Stephen Jolles
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.